1428765-63-2

Upstream product

• 1402585-79-8 (±)-methyl 2-(3-fluoro-4-iodophenyl)propanoate 
• 90500-55-3 (±)-methyl 2-(4-amino-3-fluorophenyl)propanoate 
• 86790-39-8 (±)-methyl 2-(4-nitro-3-fluorophenyl)propanoate 
• 1428765-32-5 (2-m-tolyl-6-(trifluoromethyl)pyridin-3-yl)methanamine 
• 1402585-20-9 2-(4-cyano-3-fluorophenyl)propanoic acid 
• 1428765-31-4 2-m-tolyl-6-(trifluoromethyl)nicotinonitrile 
• 17933-03-8 m-tolylboronic acid 
• 386704-06-9 2-chloro-6-(trifluoromethyl)nicotinonitrile 

Downstream Products

• 1428765-01-8 2-(3-fluoro-4-((sulfamoylamino)methyl)phenyl)-N-((2-m-tolyl-6-(trifluoromethyl)pyridin-3-yl)methyl)propanamide 
• 1428765-64-3 2-(4-(aminomethyl)-3-fluorophenyl)-N-((2-m-tolyl-6-(trifluoromethyl)pyridin-3-yl)methyl)propanamide 
• 1428765-65-4 tert-butyl N-(2-fluoro-4-(1-oxo-1-((2-m-tolyl-6-(trifluoromethyl)pyridin-3-yl)methylamino)propan-2-yl)benzyl)sulfamoylcarbamate 

Relevant academic research and scientific papers

ARYL OR N-HETEROARYL SUBSTITUTED METHANESULFONAMIDE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS

The invention relates to aryl or N-heteroaryl substituted methanesulfonamide derivatives of Formula (I) as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands

The invention relates to aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.